4//SEC Filing
Vignola Mark J. 4
Accession 0001562180-24-000639
CIK 0001831363other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 7:17 PM ET
Size
7.8 KB
Accession
0001562180-24-000639
Insider Transaction Report
Form 4
Vignola Mark J.
Chief Financial Officer
Transactions
- Award
Common Stock
2024-01-23+68,750→ 87,149 total - Award
Stock Option (Right to Buy)
2024-01-23+137,500→ 137,500 totalExercise: $5.46Exp: 2034-01-22→ Common Stock (137,500 underlying)
Footnotes (2)
- [F1]Each share is represented by a Restricted Stock Unit ("RSU"). 25% of the RSUs vest on the first anniversary measured from January 1, 2024 (the "Vesting Commencement Date"), and 1/16th of the total number of shares vest quarterly thereafter, such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date.
- [F2]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
Terns Pharmaceuticals, Inc.
CIK 0001831363
Entity typeother
Related Parties
1- filerCIK 0001775429
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 7:17 PM ET
- Size
- 7.8 KB